UPDATE 1-Portola's long-acting blood thinner misses main study goal
March 24 (Reuters) - Portola Pharmaceuticals Inc said late-stage data showed its oral anticoagulant was not superior to an injectable standard therapy in preventing blood clots in acutely ill...
No comments:
Post a Comment